KTC
SKBI

Kistler-Tiffany Companies’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Kistler-Tiffany Companies’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-500
Closed -$1K – 648
2015
Q2 		$1K Hold
500
– – ﹤0.01% 602
2015
Q1 		$2K Hold
500
– – ﹤0.01% 545
2014
Q4 		$2K Buy
+500
New +$2.16K ﹤0.01% 551

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kistler-Tiffany Companies's SKBI Position: Q3 2015 in Review

Kistler-Tiffany Companies sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q3 2015, closing a stake of 500 shares — an estimated $1K sold.

Kistler-Tiffany Companies first reported a position in SKBI in Q4 2014 and held it in 3 quarters. The position peaked at $2K in Q1 2015. 10 funds tracked by Wall St. Rank hold SKBI as of Q3 2015.

  • Kistler-Tiffany Companies reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q3 2015 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 500 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q3 2015, an estimated $1K.
  • Kistler-Tiffany Companies first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q4 2014 and held it in 3 quarters.
  • Kistler-Tiffany Companies's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $2K in Q1 2015.
  • 10 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q3 2015.

Based on Kistler-Tiffany Companies's 13F filing for Q3 2015, filed 6 Nov 2015.